Lanzamiento Enero 2027

Ensayo controlado aleatorizado2019

The effect of CYP1A2 genotype on the ergogenic properties of caffeine during resistance exercise: a randomized, double-blind, placebo-controlled, crossover study

Rahimi R

Irish journal of medical science · 46 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Universidad u hospital
University of Kurdistan
Subvenciones
University of Kurdistan (grant number 14/20137; Monday, 13 July 2015)

Según 1 financiador declarado.

Publicación

Publicado
2018-03-12 · Ir J Med Sci · vol. 188 · número 1 · págs. 337–345
Editorial
Springer Science+Business Media
Citado
62 citas · más que el 95% de estudios similares · 4.1× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
38 trabajos
Acceso
De pago
Áreas de investigación
Coffee research and impacts · Genetics and Physical Performance · Pharmacogenetics and Drug Metabolism
Palabras clave
caffeine, resistance training, ergogenic aids, caffeine metabolism, genetic polymorphism, caffeine supplementation, repetitions to failure, exercise performance, resistance-trained men, bench press, leg press, shoulder press, dose-limiting side effects, caffeine withdrawal
MeSH
humans, caffeine, cytochrome p-450 cyp1a2, central nervous system stimulants, exercise, cross-over studies, double-blind method, genotype, heterozygote, homozygote, polymorphism, genetic, polymorphism, single nucleotide, alleles, adult, male, resistance training, young adult, performance-enhancing substances

1 autor

  • Rahman Rahimi🇮🇷 · autor de correspondenciaUniversity of Kurdistan

Resumen

El texto original del estudio, en el idioma en que se publicó.

Aim

The purpose of this study was to examine the effect of CYP1A2 -163C>A polymorphism on the ergogenic effects of caffeine supplementation during a resistance exercise (RE) session.

Methods

In a randomized, double-blind, placebo (PL)-controlled, crossover study, 30 resistance-trained men took part in two RE sessions (three sets to failure at 85% of one repetition maximum, 2-min rest between sets), including bench press (BP), leg press (LP), seated cable row, and shoulder press (SP) following caffeine (CAF) (6 mg kg-1) or PL (6 mg kg-1 of maltodextrin) ingestion 1 h prior to the trial. The number of repetitions was recorded after each set, along with calculation of total number of repetitions for each exercise. Genomic DNA was isolated from the whole blood samples for analyzing the CYP1A2 -163C>A polymorphism through amplification refractory mutation system-polymerase chain reaction (ARMS-PCR). Subjects were classified as either AA (n = 14) or AC/CC genotypes (n = 16).

Results

The two-way ANOVA with repeated measures revealed differences between AAs and AC/CCs under CAF conditions for repetitions performed in sets 1, 2, and 3 of BP (F(1, 28) = 14.84, P = 0.001, ƞ2 = 0.34), LP (F(1, 28) = 8.92, P = 0.006, ƞ2 = 0.24), SR (F(1, 28) = 17.38, P = 0.0001, ƞ2 = 0.38), and SP (F(1, 28) = 3.76, P = 0.063, ƞ2 = 0.11). CAF also increased the total number of repetitions performed for all three sets in AAs versus AC/CCs for BP (F(1, 28) = 8.72, P = 0.006, ƞ2 = 0.23), LP (F(1, 28) = 4.67, P = 0.03, ƞ2 = 0.14), SR (F(1, 28) = 5.54, P = 0.02, ƞ2 = 0.16), and SP (F(1, 28) = 3.89, P = 0.058, ƞ2 = 0.12) in athletes who were homozygous carriers of the A allele, compared to the C allele carriers. Therefore, AA homozygotes were able to carry out a greater total volume of RE work under CAF but not PL conditions, compared to the C allele carriers.

Conclusion

In conclusion, acute ingestion of CAF significantly enhanced RE performance in resistance-trained men who were homozygous for the A allele, but not for C allele carriers. Further studies are needed to replicate the potential role of the CYP1A2 -163C>A polymorphism on the ergogenic effects of CAF in other modes of exercise and in other populations.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.